HCW Biologics (HCWB) Accumulated Depreciation & Amortization (2020 - 2024)
Historic Accumulated Depreciation & Amortization for HCW Biologics (HCWB) over the last 5 years, with Q4 2024 value amounting to $3.7 million.
- HCW Biologics' Accumulated Depreciation & Amortization rose 2126.16% to $3.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.7 million, marking a year-over-year increase of 2126.16%. This contributed to the annual value of $3.7 million for FY2024, which is 2126.16% up from last year.
- HCW Biologics' Accumulated Depreciation & Amortization amounted to $3.7 million in Q4 2024, which was up 2126.16% from $3.0 million recorded in Q4 2023.
- HCW Biologics' 5-year Accumulated Depreciation & Amortization high stood at $3.7 million for Q4 2024, and its period low was $1.1 million during Q4 2020.
- Its 5-year average for Accumulated Depreciation & Amortization is $2.3 million, with a median of $2.2 million in 2022.
- In the last 5 years, HCW Biologics' Accumulated Depreciation & Amortization surged by 4923.84% in 2021 and then soared by 2126.16% in 2024.
- Over the past 5 years, HCW Biologics' Accumulated Depreciation & Amortization (Quarter) stood at $1.1 million in 2020, then surged by 49.24% to $1.6 million in 2021, then soared by 35.79% to $2.2 million in 2022, then skyrocketed by 35.52% to $3.0 million in 2023, then rose by 21.26% to $3.7 million in 2024.
- Its last three reported values are $3.7 million in Q4 2024, $3.0 million for Q4 2023, and $2.2 million during Q4 2022.